Common Stock, Shares, Outstanding of Coherus Oncology, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Coherus Oncology, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Coherus Oncology, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 121,154,925, a 4.8% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Coherus Oncology, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 121,154,925 +5,540,377 +4.8% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 116,236,018 +1,022,611 +0.89% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 116,222,726 +1,024,071 +0.89% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 115,907,216 +2,410,362 +2.1% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 115,614,548 +3,399,288 +3% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 115,213,407 +6,100,361 +5.6% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 115,198,655 +20,756,641 +22% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 113,496,854 +33,008,558 +41% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 112,215,260 +33,363,744 +42% 31 Dec 2023 8-K 13 Nov 2025
Q3 2023 109,113,046 +31,342,453 +40% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 94,442,014 +16,739,265 +22% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 80,488,296 +3,150,125 +4.1% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 78,851,516 +1,921,420 +2.5% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 77,770,593 +1,187,314 +1.6% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 77,702,749 +1,238,049 +1.6% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 77,338,171 +4,215,263 +5.8% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 76,930,096 +4,416,748 +6.1% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 76,583,279 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 76,464,700 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 73,122,908 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 72,513,348 +2,146,687 +3.1% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q4 2019 70,366,661 +2,063,980 +3% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 68,302,681 +8,462,214 +14% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 59,840,467 +14,032,304 +31% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 45,808,163 +6,802,574 +17% 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q4 2015 39,005,589 +5,747,611 +17% 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q3 2015 33,257,978 +28,633,546 +619% 30 Sep 2015 10-Q 10 Nov 2015 2015 Q3
Q2 2015 33,257,978 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 33,257,978 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 33,257,978 +28,420,263 +587% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 4,624,432 30 Sep 2014 10-Q 15 Dec 2014 2014 Q3
Q4 2013 4,837,715 31 Dec 2013 10-K 23 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.